RTI Surgical upgraded to Buy from Hold at Canaccord As previously reported, Canaccord upgraded RTI Surgical to Buy from Neutral. The firm upgraded shares following the better than expected Q1 report and guidance citing a turnaround in the core business and strong momentum. Price target raised to $5 from $4.
News For RTIX From The Last 14 Days
Check below for free stories on RTIX the last two weeks.